nodes	percent_of_prediction	percent_of_DWPC	metapath
Sparfloxacin—TOP2A—Epirubicin—testicular cancer	0.147	0.182	CbGbCtD
Sparfloxacin—TOP2A—Etoposide—testicular cancer	0.115	0.142	CbGbCtD
Sparfloxacin—SLC22A5—Dactinomycin—testicular cancer	0.107	0.132	CbGbCtD
Sparfloxacin—TOP2A—Doxorubicin—testicular cancer	0.0783	0.0967	CbGbCtD
Sparfloxacin—ABCC2—Carboplatin—testicular cancer	0.0561	0.0692	CbGbCtD
Sparfloxacin—ABCC2—Vinblastine—testicular cancer	0.0523	0.0645	CbGbCtD
Sparfloxacin—ABCC2—Cisplatin—testicular cancer	0.0479	0.0592	CbGbCtD
Sparfloxacin—ABCC2—Etoposide—testicular cancer	0.0471	0.0581	CbGbCtD
Sparfloxacin—ABCC2—Doxorubicin—testicular cancer	0.0321	0.0397	CbGbCtD
Sparfloxacin—ABCC2—Methotrexate—testicular cancer	0.0311	0.0384	CbGbCtD
Sparfloxacin—ABCB1—Dactinomycin—testicular cancer	0.0272	0.0336	CbGbCtD
Sparfloxacin—ABCB1—Vinblastine—testicular cancer	0.017	0.021	CbGbCtD
Sparfloxacin—ABCB1—Cisplatin—testicular cancer	0.0156	0.0193	CbGbCtD
Sparfloxacin—ABCB1—Etoposide—testicular cancer	0.0154	0.019	CbGbCtD
Sparfloxacin—ABCB1—Doxorubicin—testicular cancer	0.0105	0.0129	CbGbCtD
Sparfloxacin—ABCB1—Methotrexate—testicular cancer	0.0101	0.0125	CbGbCtD
Sparfloxacin—TOP2A—Vindesine—Vinblastine—testicular cancer	0.000971	0.188	CbGdCrCtD
Sparfloxacin—TOP2A—Vinorelbine—Vinblastine—testicular cancer	0.000613	0.118	CbGdCrCtD
Sparfloxacin—TOP2A—Podofilox—Etoposide—testicular cancer	0.000612	0.118	CbGdCrCtD
Sparfloxacin—TOP2A—Teniposide—Etoposide—testicular cancer	0.000612	0.118	CbGdCrCtD
Sparfloxacin—TOP2A—Vincristine—Vinblastine—testicular cancer	0.000524	0.101	CbGdCrCtD
Sparfloxacin—TOP2A—Doxorubicin—Epirubicin—testicular cancer	0.000319	0.0617	CbGdCrCtD
Sparfloxacin—TOP2A—Idarubicin—Epirubicin—testicular cancer	0.000319	0.0617	CbGdCrCtD
Sparfloxacin—TOP2A—Daunorubicin—Epirubicin—testicular cancer	0.000319	0.0617	CbGdCrCtD
Sparfloxacin—TOP2A—Idarubicin—Doxorubicin—testicular cancer	0.000295	0.0571	CbGdCrCtD
Sparfloxacin—TOP2A—Daunorubicin—Doxorubicin—testicular cancer	0.000295	0.0571	CbGdCrCtD
Sparfloxacin—TOP2A—Epirubicin—Doxorubicin—testicular cancer	0.000295	0.0571	CbGdCrCtD
Sparfloxacin—Stevens-Johnson syndrome—Methotrexate—testicular cancer	0.000146	0.000789	CcSEcCtD
Sparfloxacin—Alanine aminotransferase increased—Doxorubicin—testicular cancer	0.000146	0.000789	CcSEcCtD
Sparfloxacin—Dysuria—Epirubicin—testicular cancer	0.000144	0.000781	CcSEcCtD
Sparfloxacin—Stomatitis—Methotrexate—testicular cancer	0.000143	0.000776	CcSEcCtD
Sparfloxacin—Conjunctivitis—Methotrexate—testicular cancer	0.000143	0.000774	CcSEcCtD
Sparfloxacin—Asthma—Doxorubicin—testicular cancer	0.000143	0.000773	CcSEcCtD
Sparfloxacin—Asthenia—Ifosfamide—testicular cancer	0.000142	0.00077	CcSEcCtD
Sparfloxacin—Sweating—Methotrexate—testicular cancer	0.000141	0.000763	CcSEcCtD
Sparfloxacin—Photosensitivity reaction—Epirubicin—testicular cancer	0.000141	0.000762	CcSEcCtD
Sparfloxacin—Feeling abnormal—Cisplatin—testicular cancer	0.000141	0.000762	CcSEcCtD
Sparfloxacin—Paraesthesia—Etoposide—testicular cancer	0.000141	0.000761	CcSEcCtD
Sparfloxacin—Pruritus—Ifosfamide—testicular cancer	0.00014	0.000759	CcSEcCtD
Sparfloxacin—Haematuria—Methotrexate—testicular cancer	0.00014	0.000759	CcSEcCtD
Sparfloxacin—Pancreatitis—Doxorubicin—testicular cancer	0.00014	0.000758	CcSEcCtD
Sparfloxacin—Dyspnoea—Etoposide—testicular cancer	0.00014	0.000756	CcSEcCtD
Sparfloxacin—Somnolence—Etoposide—testicular cancer	0.000139	0.000753	CcSEcCtD
Sparfloxacin—Angina pectoris—Doxorubicin—testicular cancer	0.000139	0.000753	CcSEcCtD
Sparfloxacin—Epistaxis—Methotrexate—testicular cancer	0.000139	0.000751	CcSEcCtD
Sparfloxacin—Pneumonia—Epirubicin—testicular cancer	0.000138	0.000749	CcSEcCtD
Sparfloxacin—Nausea—Bleomycin—testicular cancer	0.000138	0.000746	CcSEcCtD
Sparfloxacin—Vomiting—Dactinomycin—testicular cancer	0.000137	0.000744	CcSEcCtD
Sparfloxacin—Bronchitis—Doxorubicin—testicular cancer	0.000137	0.000743	CcSEcCtD
Sparfloxacin—Agranulocytosis—Methotrexate—testicular cancer	0.000137	0.000743	CcSEcCtD
Sparfloxacin—Stevens-Johnson syndrome—Epirubicin—testicular cancer	0.000136	0.000738	CcSEcCtD
Sparfloxacin—Rash—Dactinomycin—testicular cancer	0.000136	0.000738	CcSEcCtD
Sparfloxacin—Decreased appetite—Etoposide—testicular cancer	0.000136	0.000737	CcSEcCtD
Sparfloxacin—Diarrhoea—Ifosfamide—testicular cancer	0.000136	0.000734	CcSEcCtD
Sparfloxacin—Pancytopenia—Doxorubicin—testicular cancer	0.000136	0.000734	CcSEcCtD
Sparfloxacin—Body temperature increased—Cisplatin—testicular cancer	0.000135	0.000731	CcSEcCtD
Sparfloxacin—Jaundice—Epirubicin—testicular cancer	0.000134	0.000726	CcSEcCtD
Sparfloxacin—Stomatitis—Epirubicin—testicular cancer	0.000134	0.000726	CcSEcCtD
Sparfloxacin—Pain—Etoposide—testicular cancer	0.000134	0.000725	CcSEcCtD
Sparfloxacin—Constipation—Etoposide—testicular cancer	0.000134	0.000725	CcSEcCtD
Sparfloxacin—Urinary tract infection—Epirubicin—testicular cancer	0.000134	0.000724	CcSEcCtD
Sparfloxacin—Conjunctivitis—Epirubicin—testicular cancer	0.000134	0.000724	CcSEcCtD
Sparfloxacin—Dysuria—Doxorubicin—testicular cancer	0.000133	0.000723	CcSEcCtD
Sparfloxacin—Haemoglobin—Methotrexate—testicular cancer	0.000133	0.000718	CcSEcCtD
Sparfloxacin—Hepatitis—Methotrexate—testicular cancer	0.000132	0.000714	CcSEcCtD
Sparfloxacin—Haemorrhage—Methotrexate—testicular cancer	0.000132	0.000714	CcSEcCtD
Sparfloxacin—Sweating—Epirubicin—testicular cancer	0.000132	0.000714	CcSEcCtD
Sparfloxacin—Haematuria—Epirubicin—testicular cancer	0.000131	0.00071	CcSEcCtD
Sparfloxacin—Dizziness—Ifosfamide—testicular cancer	0.000131	0.00071	CcSEcCtD
Sparfloxacin—Pharyngitis—Methotrexate—testicular cancer	0.000131	0.000709	CcSEcCtD
Sparfloxacin—Photosensitivity reaction—Doxorubicin—testicular cancer	0.00013	0.000705	CcSEcCtD
Sparfloxacin—Epistaxis—Epirubicin—testicular cancer	0.00013	0.000703	CcSEcCtD
Sparfloxacin—Sinusitis—Epirubicin—testicular cancer	0.000129	0.000699	CcSEcCtD
Sparfloxacin—Feeling abnormal—Etoposide—testicular cancer	0.000129	0.000698	CcSEcCtD
Sparfloxacin—Nausea—Dactinomycin—testicular cancer	0.000128	0.000695	CcSEcCtD
Sparfloxacin—Agranulocytosis—Epirubicin—testicular cancer	0.000128	0.000695	CcSEcCtD
Sparfloxacin—Pneumonia—Doxorubicin—testicular cancer	0.000128	0.000693	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Etoposide—testicular cancer	0.000128	0.000693	CcSEcCtD
Sparfloxacin—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.000126	0.000683	CcSEcCtD
Sparfloxacin—Vomiting—Ifosfamide—testicular cancer	0.000126	0.000682	CcSEcCtD
Sparfloxacin—Hypersensitivity—Cisplatin—testicular cancer	0.000126	0.000682	CcSEcCtD
Sparfloxacin—Rash—Ifosfamide—testicular cancer	0.000125	0.000677	CcSEcCtD
Sparfloxacin—Dermatitis—Ifosfamide—testicular cancer	0.000125	0.000676	CcSEcCtD
Sparfloxacin—Erythema multiforme—Methotrexate—testicular cancer	0.000125	0.000676	CcSEcCtD
Sparfloxacin—Urticaria—Etoposide—testicular cancer	0.000124	0.000673	CcSEcCtD
Sparfloxacin—Haemoglobin—Epirubicin—testicular cancer	0.000124	0.000672	CcSEcCtD
Sparfloxacin—Stomatitis—Doxorubicin—testicular cancer	0.000124	0.000672	CcSEcCtD
Sparfloxacin—Jaundice—Doxorubicin—testicular cancer	0.000124	0.000672	CcSEcCtD
Sparfloxacin—Rhinitis—Epirubicin—testicular cancer	0.000124	0.00067	CcSEcCtD
Sparfloxacin—Abdominal pain—Etoposide—testicular cancer	0.000124	0.00067	CcSEcCtD
Sparfloxacin—Body temperature increased—Etoposide—testicular cancer	0.000124	0.00067	CcSEcCtD
Sparfloxacin—Urinary tract infection—Doxorubicin—testicular cancer	0.000124	0.00067	CcSEcCtD
Sparfloxacin—Conjunctivitis—Doxorubicin—testicular cancer	0.000124	0.00067	CcSEcCtD
Sparfloxacin—Hepatitis—Epirubicin—testicular cancer	0.000123	0.000669	CcSEcCtD
Sparfloxacin—Haemorrhage—Epirubicin—testicular cancer	0.000123	0.000669	CcSEcCtD
Sparfloxacin—Tinnitus—Methotrexate—testicular cancer	0.000123	0.000666	CcSEcCtD
Sparfloxacin—Hypoaesthesia—Epirubicin—testicular cancer	0.000123	0.000665	CcSEcCtD
Sparfloxacin—Asthenia—Cisplatin—testicular cancer	0.000123	0.000664	CcSEcCtD
Sparfloxacin—Pharyngitis—Epirubicin—testicular cancer	0.000123	0.000664	CcSEcCtD
Sparfloxacin—Sweating—Doxorubicin—testicular cancer	0.000122	0.000661	CcSEcCtD
Sparfloxacin—Oedema peripheral—Epirubicin—testicular cancer	0.000122	0.000659	CcSEcCtD
Sparfloxacin—Haematuria—Doxorubicin—testicular cancer	0.000121	0.000657	CcSEcCtD
Sparfloxacin—Epistaxis—Doxorubicin—testicular cancer	0.00012	0.00065	CcSEcCtD
Sparfloxacin—Sinusitis—Doxorubicin—testicular cancer	0.000119	0.000647	CcSEcCtD
Sparfloxacin—Agranulocytosis—Doxorubicin—testicular cancer	0.000119	0.000643	CcSEcCtD
Sparfloxacin—Chills—Methotrexate—testicular cancer	0.000118	0.000641	CcSEcCtD
Sparfloxacin—Nausea—Ifosfamide—testicular cancer	0.000118	0.000637	CcSEcCtD
Sparfloxacin—Diarrhoea—Cisplatin—testicular cancer	0.000117	0.000633	CcSEcCtD
Sparfloxacin—Erythema multiforme—Epirubicin—testicular cancer	0.000117	0.000632	CcSEcCtD
Sparfloxacin—Alopecia—Methotrexate—testicular cancer	0.000117	0.000631	CcSEcCtD
Sparfloxacin—Hypersensitivity—Etoposide—testicular cancer	0.000115	0.000624	CcSEcCtD
Sparfloxacin—Tinnitus—Epirubicin—testicular cancer	0.000115	0.000623	CcSEcCtD
Sparfloxacin—Haemoglobin—Doxorubicin—testicular cancer	0.000115	0.000622	CcSEcCtD
Sparfloxacin—Rhinitis—Doxorubicin—testicular cancer	0.000115	0.00062	CcSEcCtD
Sparfloxacin—Haemorrhage—Doxorubicin—testicular cancer	0.000114	0.000619	CcSEcCtD
Sparfloxacin—Hepatitis—Doxorubicin—testicular cancer	0.000114	0.000619	CcSEcCtD
Sparfloxacin—Hypoaesthesia—Doxorubicin—testicular cancer	0.000114	0.000616	CcSEcCtD
Sparfloxacin—Pharyngitis—Doxorubicin—testicular cancer	0.000113	0.000614	CcSEcCtD
Sparfloxacin—Oedema peripheral—Doxorubicin—testicular cancer	0.000113	0.000609	CcSEcCtD
Sparfloxacin—Dysgeusia—Methotrexate—testicular cancer	0.000112	0.000609	CcSEcCtD
Sparfloxacin—Asthenia—Etoposide—testicular cancer	0.000112	0.000608	CcSEcCtD
Sparfloxacin—Back pain—Methotrexate—testicular cancer	0.000111	0.000602	CcSEcCtD
Sparfloxacin—Chills—Epirubicin—testicular cancer	0.000111	0.0006	CcSEcCtD
Sparfloxacin—Pruritus—Etoposide—testicular cancer	0.000111	0.0006	CcSEcCtD
Sparfloxacin—Arrhythmia—Epirubicin—testicular cancer	0.00011	0.000597	CcSEcCtD
Sparfloxacin—Alopecia—Epirubicin—testicular cancer	0.000109	0.000591	CcSEcCtD
Sparfloxacin—Vomiting—Cisplatin—testicular cancer	0.000109	0.000588	CcSEcCtD
Sparfloxacin—Erythema multiforme—Doxorubicin—testicular cancer	0.000108	0.000585	CcSEcCtD
Sparfloxacin—Rash—Cisplatin—testicular cancer	0.000108	0.000583	CcSEcCtD
Sparfloxacin—Dermatitis—Cisplatin—testicular cancer	0.000108	0.000583	CcSEcCtD
Sparfloxacin—Diarrhoea—Etoposide—testicular cancer	0.000107	0.00058	CcSEcCtD
Sparfloxacin—Ill-defined disorder—Methotrexate—testicular cancer	0.000107	0.000577	CcSEcCtD
Sparfloxacin—Tinnitus—Doxorubicin—testicular cancer	0.000107	0.000577	CcSEcCtD
Sparfloxacin—Flatulence—Epirubicin—testicular cancer	0.000106	0.000574	CcSEcCtD
Sparfloxacin—Tension—Epirubicin—testicular cancer	0.000105	0.000571	CcSEcCtD
Sparfloxacin—Dysgeusia—Epirubicin—testicular cancer	0.000105	0.00057	CcSEcCtD
Sparfloxacin—Nervousness—Epirubicin—testicular cancer	0.000104	0.000565	CcSEcCtD
Sparfloxacin—Back pain—Epirubicin—testicular cancer	0.000104	0.000563	CcSEcCtD
Sparfloxacin—Malaise—Methotrexate—testicular cancer	0.000104	0.000561	CcSEcCtD
Sparfloxacin—Dizziness—Etoposide—testicular cancer	0.000103	0.00056	CcSEcCtD
Sparfloxacin—Vertigo—Methotrexate—testicular cancer	0.000103	0.000559	CcSEcCtD
Sparfloxacin—Chills—Doxorubicin—testicular cancer	0.000103	0.000555	CcSEcCtD
Sparfloxacin—Arrhythmia—Doxorubicin—testicular cancer	0.000102	0.000553	CcSEcCtD
Sparfloxacin—Nausea—Cisplatin—testicular cancer	0.000101	0.000549	CcSEcCtD
Sparfloxacin—Alopecia—Doxorubicin—testicular cancer	0.000101	0.000547	CcSEcCtD
Sparfloxacin—Cough—Methotrexate—testicular cancer	0.0001	0.000543	CcSEcCtD
Sparfloxacin—Ill-defined disorder—Epirubicin—testicular cancer	9.97e-05	0.00054	CcSEcCtD
Sparfloxacin—Convulsion—Methotrexate—testicular cancer	9.95e-05	0.000539	CcSEcCtD
Sparfloxacin—Vomiting—Etoposide—testicular cancer	9.95e-05	0.000539	CcSEcCtD
Sparfloxacin—Agitation—Epirubicin—testicular cancer	9.88e-05	0.000535	CcSEcCtD
Sparfloxacin—Rash—Etoposide—testicular cancer	9.87e-05	0.000534	CcSEcCtD
Sparfloxacin—Dermatitis—Etoposide—testicular cancer	9.86e-05	0.000534	CcSEcCtD
Sparfloxacin—Headache—Etoposide—testicular cancer	9.8e-05	0.000531	CcSEcCtD
Sparfloxacin—Flatulence—Doxorubicin—testicular cancer	9.8e-05	0.000531	CcSEcCtD
Sparfloxacin—Arthralgia—Methotrexate—testicular cancer	9.78e-05	0.000529	CcSEcCtD
Sparfloxacin—Chest pain—Methotrexate—testicular cancer	9.78e-05	0.000529	CcSEcCtD
Sparfloxacin—Myalgia—Methotrexate—testicular cancer	9.78e-05	0.000529	CcSEcCtD
Sparfloxacin—Tension—Doxorubicin—testicular cancer	9.76e-05	0.000528	CcSEcCtD
Sparfloxacin—Dysgeusia—Doxorubicin—testicular cancer	9.74e-05	0.000527	CcSEcCtD
Sparfloxacin—Malaise—Epirubicin—testicular cancer	9.69e-05	0.000525	CcSEcCtD
Sparfloxacin—Discomfort—Methotrexate—testicular cancer	9.66e-05	0.000523	CcSEcCtD
Sparfloxacin—Nervousness—Doxorubicin—testicular cancer	9.66e-05	0.000523	CcSEcCtD
Sparfloxacin—Vertigo—Epirubicin—testicular cancer	9.66e-05	0.000523	CcSEcCtD
Sparfloxacin—Back pain—Doxorubicin—testicular cancer	9.62e-05	0.000521	CcSEcCtD
Sparfloxacin—Palpitations—Epirubicin—testicular cancer	9.5e-05	0.000514	CcSEcCtD
Sparfloxacin—Confusional state—Methotrexate—testicular cancer	9.45e-05	0.000512	CcSEcCtD
Sparfloxacin—Cough—Epirubicin—testicular cancer	9.38e-05	0.000508	CcSEcCtD
Sparfloxacin—Anaphylactic shock—Methotrexate—testicular cancer	9.37e-05	0.000508	CcSEcCtD
Sparfloxacin—Convulsion—Epirubicin—testicular cancer	9.31e-05	0.000504	CcSEcCtD
Sparfloxacin—Nausea—Etoposide—testicular cancer	9.3e-05	0.000503	CcSEcCtD
Sparfloxacin—Hypertension—Epirubicin—testicular cancer	9.28e-05	0.000503	CcSEcCtD
Sparfloxacin—Ill-defined disorder—Doxorubicin—testicular cancer	9.23e-05	0.0005	CcSEcCtD
Sparfloxacin—Thrombocytopenia—Methotrexate—testicular cancer	9.18e-05	0.000497	CcSEcCtD
Sparfloxacin—Arthralgia—Epirubicin—testicular cancer	9.15e-05	0.000496	CcSEcCtD
Sparfloxacin—Chest pain—Epirubicin—testicular cancer	9.15e-05	0.000496	CcSEcCtD
Sparfloxacin—Myalgia—Epirubicin—testicular cancer	9.15e-05	0.000496	CcSEcCtD
Sparfloxacin—Agitation—Doxorubicin—testicular cancer	9.14e-05	0.000495	CcSEcCtD
Sparfloxacin—Anxiety—Epirubicin—testicular cancer	9.12e-05	0.000494	CcSEcCtD
Sparfloxacin—Hyperhidrosis—Methotrexate—testicular cancer	9.06e-05	0.000491	CcSEcCtD
Sparfloxacin—Discomfort—Epirubicin—testicular cancer	9.04e-05	0.00049	CcSEcCtD
Sparfloxacin—Malaise—Doxorubicin—testicular cancer	8.97e-05	0.000486	CcSEcCtD
Sparfloxacin—Dry mouth—Epirubicin—testicular cancer	8.95e-05	0.000485	CcSEcCtD
Sparfloxacin—Vertigo—Doxorubicin—testicular cancer	8.94e-05	0.000484	CcSEcCtD
Sparfloxacin—Anorexia—Methotrexate—testicular cancer	8.93e-05	0.000484	CcSEcCtD
Sparfloxacin—Confusional state—Epirubicin—testicular cancer	8.84e-05	0.000479	CcSEcCtD
Sparfloxacin—Palpitations—Doxorubicin—testicular cancer	8.79e-05	0.000476	CcSEcCtD
Sparfloxacin—Anaphylactic shock—Epirubicin—testicular cancer	8.77e-05	0.000475	CcSEcCtD
Sparfloxacin—Cough—Doxorubicin—testicular cancer	8.68e-05	0.00047	CcSEcCtD
Sparfloxacin—Convulsion—Doxorubicin—testicular cancer	8.62e-05	0.000467	CcSEcCtD
Sparfloxacin—Thrombocytopenia—Epirubicin—testicular cancer	8.59e-05	0.000465	CcSEcCtD
Sparfloxacin—Hypertension—Doxorubicin—testicular cancer	8.59e-05	0.000465	CcSEcCtD
Sparfloxacin—Tachycardia—Epirubicin—testicular cancer	8.56e-05	0.000464	CcSEcCtD
Sparfloxacin—Musculoskeletal discomfort—Methotrexate—testicular cancer	8.54e-05	0.000462	CcSEcCtD
Sparfloxacin—Hyperhidrosis—Epirubicin—testicular cancer	8.48e-05	0.000459	CcSEcCtD
Sparfloxacin—Insomnia—Methotrexate—testicular cancer	8.48e-05	0.000459	CcSEcCtD
Sparfloxacin—Myalgia—Doxorubicin—testicular cancer	8.47e-05	0.000458	CcSEcCtD
Sparfloxacin—Arthralgia—Doxorubicin—testicular cancer	8.47e-05	0.000458	CcSEcCtD
Sparfloxacin—Chest pain—Doxorubicin—testicular cancer	8.47e-05	0.000458	CcSEcCtD
Sparfloxacin—Anxiety—Doxorubicin—testicular cancer	8.44e-05	0.000457	CcSEcCtD
Sparfloxacin—Paraesthesia—Methotrexate—testicular cancer	8.42e-05	0.000456	CcSEcCtD
Sparfloxacin—Discomfort—Doxorubicin—testicular cancer	8.37e-05	0.000453	CcSEcCtD
Sparfloxacin—Anorexia—Epirubicin—testicular cancer	8.36e-05	0.000453	CcSEcCtD
Sparfloxacin—Dyspnoea—Methotrexate—testicular cancer	8.36e-05	0.000453	CcSEcCtD
Sparfloxacin—Somnolence—Methotrexate—testicular cancer	8.33e-05	0.000451	CcSEcCtD
Sparfloxacin—Dry mouth—Doxorubicin—testicular cancer	8.28e-05	0.000448	CcSEcCtD
Sparfloxacin—Dyspepsia—Methotrexate—testicular cancer	8.25e-05	0.000447	CcSEcCtD
Sparfloxacin—Confusional state—Doxorubicin—testicular cancer	8.18e-05	0.000443	CcSEcCtD
Sparfloxacin—Decreased appetite—Methotrexate—testicular cancer	8.15e-05	0.000441	CcSEcCtD
Sparfloxacin—Anaphylactic shock—Doxorubicin—testicular cancer	8.12e-05	0.00044	CcSEcCtD
Sparfloxacin—Pain—Methotrexate—testicular cancer	8.02e-05	0.000434	CcSEcCtD
Sparfloxacin—Musculoskeletal discomfort—Epirubicin—testicular cancer	7.99e-05	0.000433	CcSEcCtD
Sparfloxacin—Thrombocytopenia—Doxorubicin—testicular cancer	7.95e-05	0.00043	CcSEcCtD
Sparfloxacin—Insomnia—Epirubicin—testicular cancer	7.93e-05	0.00043	CcSEcCtD
Sparfloxacin—Tachycardia—Doxorubicin—testicular cancer	7.92e-05	0.000429	CcSEcCtD
Sparfloxacin—Paraesthesia—Epirubicin—testicular cancer	7.88e-05	0.000427	CcSEcCtD
Sparfloxacin—Hyperhidrosis—Doxorubicin—testicular cancer	7.85e-05	0.000425	CcSEcCtD
Sparfloxacin—Dyspnoea—Epirubicin—testicular cancer	7.82e-05	0.000424	CcSEcCtD
Sparfloxacin—Somnolence—Epirubicin—testicular cancer	7.8e-05	0.000422	CcSEcCtD
Sparfloxacin—Anorexia—Doxorubicin—testicular cancer	7.74e-05	0.000419	CcSEcCtD
Sparfloxacin—Feeling abnormal—Methotrexate—testicular cancer	7.72e-05	0.000418	CcSEcCtD
Sparfloxacin—Dyspepsia—Epirubicin—testicular cancer	7.72e-05	0.000418	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Methotrexate—testicular cancer	7.66e-05	0.000415	CcSEcCtD
Sparfloxacin—Decreased appetite—Epirubicin—testicular cancer	7.63e-05	0.000413	CcSEcCtD
Sparfloxacin—Pain—Epirubicin—testicular cancer	7.5e-05	0.000406	CcSEcCtD
Sparfloxacin—Constipation—Epirubicin—testicular cancer	7.5e-05	0.000406	CcSEcCtD
Sparfloxacin—Urticaria—Methotrexate—testicular cancer	7.45e-05	0.000403	CcSEcCtD
Sparfloxacin—Abdominal pain—Methotrexate—testicular cancer	7.41e-05	0.000401	CcSEcCtD
Sparfloxacin—Body temperature increased—Methotrexate—testicular cancer	7.41e-05	0.000401	CcSEcCtD
Sparfloxacin—Musculoskeletal discomfort—Doxorubicin—testicular cancer	7.39e-05	0.0004	CcSEcCtD
Sparfloxacin—Insomnia—Doxorubicin—testicular cancer	7.34e-05	0.000398	CcSEcCtD
Sparfloxacin—Paraesthesia—Doxorubicin—testicular cancer	7.29e-05	0.000395	CcSEcCtD
Sparfloxacin—Dyspnoea—Doxorubicin—testicular cancer	7.24e-05	0.000392	CcSEcCtD
Sparfloxacin—Feeling abnormal—Epirubicin—testicular cancer	7.23e-05	0.000391	CcSEcCtD
Sparfloxacin—Somnolence—Doxorubicin—testicular cancer	7.22e-05	0.000391	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Epirubicin—testicular cancer	7.17e-05	0.000388	CcSEcCtD
Sparfloxacin—Dyspepsia—Doxorubicin—testicular cancer	7.14e-05	0.000387	CcSEcCtD
Sparfloxacin—Decreased appetite—Doxorubicin—testicular cancer	7.06e-05	0.000382	CcSEcCtD
Sparfloxacin—Urticaria—Epirubicin—testicular cancer	6.97e-05	0.000377	CcSEcCtD
Sparfloxacin—Pain—Doxorubicin—testicular cancer	6.94e-05	0.000376	CcSEcCtD
Sparfloxacin—Constipation—Doxorubicin—testicular cancer	6.94e-05	0.000376	CcSEcCtD
Sparfloxacin—Abdominal pain—Epirubicin—testicular cancer	6.93e-05	0.000376	CcSEcCtD
Sparfloxacin—Body temperature increased—Epirubicin—testicular cancer	6.93e-05	0.000376	CcSEcCtD
Sparfloxacin—Hypersensitivity—Methotrexate—testicular cancer	6.91e-05	0.000374	CcSEcCtD
Sparfloxacin—Asthenia—Methotrexate—testicular cancer	6.73e-05	0.000364	CcSEcCtD
Sparfloxacin—Feeling abnormal—Doxorubicin—testicular cancer	6.69e-05	0.000362	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Doxorubicin—testicular cancer	6.64e-05	0.000359	CcSEcCtD
Sparfloxacin—Pruritus—Methotrexate—testicular cancer	6.63e-05	0.000359	CcSEcCtD
Sparfloxacin—Hypersensitivity—Epirubicin—testicular cancer	6.46e-05	0.00035	CcSEcCtD
Sparfloxacin—Urticaria—Doxorubicin—testicular cancer	6.45e-05	0.000349	CcSEcCtD
Sparfloxacin—Abdominal pain—Doxorubicin—testicular cancer	6.42e-05	0.000347	CcSEcCtD
Sparfloxacin—Body temperature increased—Doxorubicin—testicular cancer	6.42e-05	0.000347	CcSEcCtD
Sparfloxacin—Diarrhoea—Methotrexate—testicular cancer	6.41e-05	0.000347	CcSEcCtD
Sparfloxacin—Asthenia—Epirubicin—testicular cancer	6.29e-05	0.000341	CcSEcCtD
Sparfloxacin—Pruritus—Epirubicin—testicular cancer	6.21e-05	0.000336	CcSEcCtD
Sparfloxacin—Dizziness—Methotrexate—testicular cancer	6.2e-05	0.000336	CcSEcCtD
Sparfloxacin—Diarrhoea—Epirubicin—testicular cancer	6e-05	0.000325	CcSEcCtD
Sparfloxacin—Hypersensitivity—Doxorubicin—testicular cancer	5.98e-05	0.000324	CcSEcCtD
Sparfloxacin—Vomiting—Methotrexate—testicular cancer	5.96e-05	0.000323	CcSEcCtD
Sparfloxacin—Rash—Methotrexate—testicular cancer	5.91e-05	0.00032	CcSEcCtD
Sparfloxacin—Dermatitis—Methotrexate—testicular cancer	5.9e-05	0.00032	CcSEcCtD
Sparfloxacin—Headache—Methotrexate—testicular cancer	5.87e-05	0.000318	CcSEcCtD
Sparfloxacin—Asthenia—Doxorubicin—testicular cancer	5.82e-05	0.000315	CcSEcCtD
Sparfloxacin—Dizziness—Epirubicin—testicular cancer	5.8e-05	0.000314	CcSEcCtD
Sparfloxacin—Pruritus—Doxorubicin—testicular cancer	5.74e-05	0.000311	CcSEcCtD
Sparfloxacin—Vomiting—Epirubicin—testicular cancer	5.58e-05	0.000302	CcSEcCtD
Sparfloxacin—Nausea—Methotrexate—testicular cancer	5.57e-05	0.000302	CcSEcCtD
Sparfloxacin—Diarrhoea—Doxorubicin—testicular cancer	5.55e-05	0.000301	CcSEcCtD
Sparfloxacin—Rash—Epirubicin—testicular cancer	5.53e-05	0.0003	CcSEcCtD
Sparfloxacin—Dermatitis—Epirubicin—testicular cancer	5.53e-05	0.000299	CcSEcCtD
Sparfloxacin—Headache—Epirubicin—testicular cancer	5.5e-05	0.000298	CcSEcCtD
Sparfloxacin—Dizziness—Doxorubicin—testicular cancer	5.37e-05	0.000291	CcSEcCtD
Sparfloxacin—Nausea—Epirubicin—testicular cancer	5.21e-05	0.000282	CcSEcCtD
Sparfloxacin—Vomiting—Doxorubicin—testicular cancer	5.16e-05	0.000279	CcSEcCtD
Sparfloxacin—Rash—Doxorubicin—testicular cancer	5.12e-05	0.000277	CcSEcCtD
Sparfloxacin—Dermatitis—Doxorubicin—testicular cancer	5.11e-05	0.000277	CcSEcCtD
Sparfloxacin—Headache—Doxorubicin—testicular cancer	5.08e-05	0.000275	CcSEcCtD
Sparfloxacin—Nausea—Doxorubicin—testicular cancer	4.82e-05	0.000261	CcSEcCtD
